|
|
|
|
|
|
OMB APPROVAL
|
|
|
|
OMB Number: 3235-0167
|
|
|
|
Expires: November 30, 2010
|
|
|
|
Estimated average burden
hours per response ..... 1.50
|
|
|
|
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION
12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE
REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission File Number: 000-23280
NEUROBIOLOGICAL TECHNOLOGIES, INC.
(Exact name of registrant as specified in its charter)
2000 Powell Street, Suite 800, Emeryville, California 94608
(510) 595-6000
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
Common Stock, $0.001 par value per share
(Title of each class of securities covered by this Form)
None
(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to
terminate or suspend the duty to file reports:
|
|
|
|
|
|
Rule 12g-4(a)(1)
|
|
o
|
|
|
Rule 12g-4(a)(2)
|
|
o
|
|
|
Rule 12h-3(b)(1)(i)
|
|
þ
|
|
|
Rule 12h-3(b)(1)(ii)
|
|
o
|
|
|
Rule 15d-6
|
|
þ
|
|
Approximate number of holders of record as of the certification or notice date: 200
Pursuant to the requirements of the Securities Exchange Act of 1934, Neurobiological Technologies, Inc. has caused this certification/notice to be signed on its behalf by the undersigned
duly authorized person.
|
|
|
|
|
|
Date: July 15, 2010
|
By:
|
/s/ MATTHEW M. LOAR
|
|
|
Name:
|
Matthew M. Loar
|
|
|
Title:
|
Acting Chief Executive and Financial Officer
|
Instruction:
This form is required by Rules 12g-4, 12h-3 and 15d-6 of the General Rules and
Regulations under the Securities Exchange Act of 1934. The registrant shall file with the
Commission three copies of Form 15, one of which shall be manually signed. It may be signed by an
officer of the registrant, by counsel or by any other duly authorized person. The name and title
of the person signing the form shall be typed or printed under the signature.
|
|
|
|
|
SEC 2069 (02-08)
|
|
Potential persons who are to respond to the collection of information contained in this form are not required to respond unless
the form displays a currently valid OMB control number.
|